What is Alumis Inc.'s contract liabilities?

Alumis Inc. (ALMS) reported contract liabilities of $2.61M in Q4 2025.

What does contract liabilities mean?

Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.

Alumis Inc. ALMS Contract Liabilities

Contract Liabilities at other companies

Kymera TherapeuticsKYMR

$0—

Aurinia PharmaceuticalsAUPH

$12.65M+644%

Other financials

Income statement

See full

Revenue$1.7M-90.0%

Operating income-$98.4M+3.1%

Net income-$93.1M+6.0%

EPS (diluted)-$0.74+59.3%

Balance sheet

See full

Cash & equivalents$63.9M-50.3%

Total debt$35.7M+1,881%

Total equity$567.0M+237%

Total assets$671.6M+157%

Cash flow

See full

Operating cash flow-$87.1M-8.4%

CapEx$164.0K+343%

Free cash flow-$87.2M-8.5%

Valuation

See full

Market cap$3.17B+739%

Enterprise value$3.14B+1,238%

P/S377.1×—

Profitability

See full

Operating margin-5,364%—

Net margin-2,825.7%—

FCF margin-4,487.4%—

Returns & leverage

See full

Return on equity-64.6%—

Debt / equity0.1×+0.1×

Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alumis Inc.'s contract liabilities?: Alumis Inc. (ALMS) reported contract liabilities of $2.61M in Q4 2025.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.